Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ebola Outbreak 2014 - News, Updates and Related Investments -- Ignore unavailable to you. Want to Upgrade?

To: statesidereport who wrote (289)	9/28/2014 9:58:10 AM
From: IRWIN JAMES FRANKEL	Read Replies (1) \| Respond to of 608

>> At some point there will simply not be enough medical staff. Did we already pass that tipping point?. Finally someone says what has been obvious for months. ZEBOV is not controlled. R0 >1 perhaps even 3. Caring for the sick takes 3 medical staff per patient. IF we have not already passed the "tipping point" we will soon. We face important unanswered questions. Do survivors carry latent virus that can rebound? Can they infect others even if they are stable? What drugs work? Which are best? Who will take charge of the epidemic given WHO is incompetent? Without a single and powerful manager of the epidemic it will continue to grow. US Military is likely the best choice to take control but it is not clear we will do that. ij